SUPN
Congressional ActivitySupernus Pharmaceuticals, Inc. -
ARIA INTELLIGENCE BRIEF
Disclosure records for this Health Care sector security show a single member of Congress, Gil Cisneros, accounting for all four disclosed trades — three purchases and one sale — spanning from March 2025 through March 2026, reflecting net buying activity over roughly a year. The record is narrow, with no bipartisan co-trading clusters identified given the single-member footprint. Separately, two executive-branch officials have disclosed four transactions in the same security across the public filing record, representing an independent sequence of disclosures with no computed purchase-to-purchase proximity to congressional activity.
Signal Congress surfaces public disclosure data. This is not investment advice and does not imply wrongdoing.
TOTAL TRADES
4
BUYS
3
SELLS
1
MEMBERS
1
unique traders
BIPARTISAN CLUSTERS
0
AVG ALPHA 60D
-4.17%
vs SPY benchmark
SUPN timeline9 trades · Congress + cabinet · convergence
Positioned by disclosure date. Click any marker for its source filing.
CongressCabinetContract cut8-K13D▲ buy ▼ sell ◆ n/a ■ event
EXECUTIVE HOLDINGS
Primary-source OGE 278-T disclosures
| OFFICIAL | AGENCY | DATE | TYPE | AMOUNT |
|---|---|---|---|---|
Trump, Donald J. President | Jul 29, 26 | SELL | $15K–$50K | |
Trump, Donald J. President | May 15, 26 | SELL | $15K–$50K | |
Lamelas, Peter | Dec 16, 25 | SELL | $1K–$15K | |
Stephens, Warren | Jul 24, 25 | SELL | $250K–$500K | |
Stephens, Warren | May 30, 25 | SELL | $15K–$50K | |
Stephens, Warren | May 29, 25 | SELL | $15K–$50K |
4 trades
Congressional trading data from STOCK Act filings. Not investment advice.